Antitumor efficacy of mammalian target of rapamycin inhibitor therapy in liver transplant recipients with oncological disease: a case-control study. (Q54484102)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Antitumor efficacy of mammalian target of rapamycin inhibitor therapy in liver transplant recipients with oncological disease: a case-control study.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974919 AND SRC:MED&resulttype=core&format=json

13 February 2020

Antitumor efficacy of mammalian target of rapamycin inhibitor therapy in liver transplant recipients with oncological disease: a case-control study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974919 AND SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

based on heuristic

inferred from title

Miguel Angel Gómez Bravo

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974919 AND SRC:MED&resulttype=core&format=json

13 February 2020

Francisco Javier Padillo Ruiz

1 reference

ORCID Public Data File 2021

author name string

J M Alamo

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974919 AND SRC:MED&resulttype=core&format=json

13 February 2020

C Bernal

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974919 AND SRC:MED&resulttype=core&format=json

13 February 2020

L M Marín

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974919 AND SRC:MED&resulttype=core&format=json

13 February 2020

G Suárez

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974919 AND SRC:MED&resulttype=core&format=json

13 February 2020

J Serrano

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974919 AND SRC:MED&resulttype=core&format=json

13 February 2020

L Barrera

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974919 AND SRC:MED&resulttype=core&format=json

13 February 2020

J M Sousa

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974919 AND SRC:MED&resulttype=core&format=json

13 February 2020

F J Padillo

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974919 AND SRC:MED&resulttype=core&format=json

13 February 2020

language of work or name

0 references

publication date

1 September 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974919 AND SRC:MED&resulttype=core&format=json

13 February 2020

Transplantation Proceedings

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974919 AND SRC:MED&resulttype=core&format=json

13 February 2020

44

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974919 AND SRC:MED&resulttype=core&format=json

13 February 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974919 AND SRC:MED&resulttype=core&format=json

13 February 2020

2089-2092

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974919 AND SRC:MED&resulttype=core&format=json

13 February 2020

Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2012.07.079

7 January 2021

Increased cancer risk after liver transplantation: a population-based study

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2012.07.079

7 January 2021

De novo malignancies after liver transplantation: a major cause of late death

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2012.07.079

7 January 2021

Usefulness of a program of neoplasia surveillance in liver transplantation. A preliminary report

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2012.07.079

7 January 2021

Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2012.07.079

7 January 2021

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2012.07.079

7 January 2021

Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2012.07.079

7 January 2021

Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2012.07.079

7 January 2021

A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2012.07.079

7 January 2021

Sirolimus-based immunosuppression in liver transplantation for hepatocellular carcinoma: A meta-analysis

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2012.07.079

7 January 2021

Posttransplant lymphoproliferative disease following liver transplantation

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2012.07.079

7 January 2021

mTOR as a therapeutic target in patients with gastric cancer

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2012.07.079

7 January 2021

Mammalian target of rapamycin expression and laryngeal squamous cell carcinoma prognosis: novel preliminary evidence.

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2012.07.079

7 January 2021

mTOR in breast cancer: differential expression in triple-negative and non-triple-negative tumors

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2012.07.079

7 January 2021

Inhibition of mTOR by temsirolimus contributes to prolonged survival of mice with pleural dissemination of non‐small‐cell lung cancer cells

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2012.07.079

7 January 2021

Identifiers

10.1016/J.TRANSPROCEED.2012.07.079

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974919 AND SRC:MED&resulttype=core&format=json

13 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22974919 AND SRC:MED&resulttype=core&format=json

13 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54484102&oldid=1589821506"